Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era

At the Center for Bioethics and Human Dignity annual summer conference “Bioethics in Real Life,” Dr. David Prentice and Dr. Tara Sander Lee presented a workshop entitled Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era.

 

Scientific advancements in the fields of genetics, molecular diagnosis, and genetic engineering were introduced so that participants could better understand the benefits, risks, limitations, policies, and potential impact on society.  The ethics were carefully evaluated and discussed, especially given that these practices can rely upon the use and manipulation of human embryos without giving proper respect and dignity for the sanctity of human life from day 1 of fertilization.

 



The first draft of the human genome was sequenced in 2001.  Since that discovery, several significant advancements have been made in defining the genes in our body and determining  what constitutes “normal” and “abnormal”.  As a result, genetic information can be used to heal and provide personalized treatment, but it can also lead to harm through eugenics and discrimination.

 

Advancements in science have resulted in a society that can now design a child that carries, or does not carry, specific traits that we as a society deem worthy or not worthy of inheritance. Who are we to decide what determines a person’s value and who deserves life? How did we get here and where are we headed? Current clinical practices in reproductive medicine and prenatal genetic testing foster this mentality of playing God and creating the “perfect” child.

 

New science technologies on the horizon are also helping to define this new era with significant challenges and risks to the human race.  Gene editing, cloning, three-parent embryos, and chimeras are all contestants in this global scientific quest for discovery and treatment of disease.

 

Read more about gene editing and ethics: Gene Editing: Charlotte Lozier Institute Articles and Op-Eds

Latest Posts

December 20, 2024 Strengthening the Pro-Life Safety Net: Federal Transportation Policy December 19, 2024 End of Year Update: Tax Credits for Life Affirming Organizations End of Year Update: Tax Credits for Life Affirming Organizations December 19, 2024 Fact Sheet: Abortions at or after 15 Weeks in the United States

You Might Also Be Interested In

In Vitro Fertilization (IVF): A Comprehensive Primer

charlotte-lozier-institute Charlotte Lozier Institute
December 17, 2024
Please login to bookmark Close

The Treatment of Human Embryos Created through IVF: The U.S. and 15 Selected Countries’ Regulations

November 22, 2024
Please login to bookmark Close

IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

November 13, 2024
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image